Home 5 Clinical Diagnostics Insider 5 FDA Watch: Agency Issues New Guidance on Biotin Interference Testing

FDA Watch: Agency Issues New Guidance on Biotin Interference Testing

by | Sep 3, 2019 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

From - Diagnostic Testing & Emerging Technologies On June 13, the FDA issued a draft guidance explaining how makers of in vitro diagnostic devices (IVDs) should perform… . . . read more

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article